GlassScriptPhysician profile
Kathleen E Bradley
NPI 1982789517
$4,676.92
in general payments reported to CMS, 2019-2025
17 companies · $586 in 2025
The $586 reported for 2025 was more than what 90% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $129 · 2021: $345 · 2022: $75.96 · 2023: $2,465 · 2024: $105 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,196 · Food and Beverage: $928 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,195.91 |
| Food and Beverage | $927.65 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonio | $2,195.91 | 2023 | |
| Ge Healthcare | $538.93 | 2019-2025 | |
| Amgen INC. | $351.02 | 2021-2025 | Otezla |
| Novo Nordisk INC | $256.59 | 2023-2025 | Tresiba |
| Intuitive Surgical, INC. | $148.95 | 2019 | |
| Therapeuticsmd, INC. | $128.88 | 2020 | |
| Amarin Pharma, INC. | $128.35 | 2019 | |
| Boston Scientific Corporation | $122.20 | 2025 | Farapulse |
| Axsome Therapeutics, INC. | $119.18 | 2025 | Symbravo |
| Biohaven Pharmaceuticals, INC. | $118.59 | 2021 | |
| Stryker Corporation | $105.13 | 2024 | Audion Et Dilation System |
| Hologic Sales and Service, LLC | $91.07 | 2019 | |
| Samsung Hme America, INC. | $89.09 | 2025 | |
| Radius Health, INC. | $86.19 | 2019 | |
| Vertiflex, INC. | $84.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $70.04 | 2023 | Epclusa |
| Dexcom, INC. | $42.63 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.